在基于多维数据的基础上,探索和验证结肠腺癌中的死细胞基因调节和相关的lncRNA机制
Weili Wang1,2, Yi Liu2, Ziqi Wang3
1Department of Oncology, The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, Changsha, China.
Scientific reports
|September 27, 2024
概括
这项研究确定了八个长非编码RNA和九个与亡相关的基因,这些基因可以预测结肠腺癌 (COAD) 的结果. 这些基因影响免疫反应和瘤进展,为COAD患者提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 亡在结肠腺癌 (COAD) 开始和进展中起着重要作用.
- 有限的研究存在于亡相关基因 (NRGs) 和它们在COAD中的调节长非编码RNA (NRGlncRNAs).
- 了解这些分子参与者对于开发新的COAD诊断和治疗方法至关重要.
研究的目的:
- 在结肠腺癌 (COAD) 中识别预后性亡相关基因 (NRGs) 和长非编码RNA (lncRNAs).
- 探索这些基因在COAD发育中的调节机制和潜在的因果关系.
- 建立基于已识别的NRG和NRGlncRNAs的COAD预后模型.
主要方法:
- 使用了癌症基因组图谱 (TCGA) 和基因表达总汇 (GEO) 数据集用于NRG和NRGlncRNA.
- 采用了Cox和最小绝对收缩和选择操作员 (LASSO) 回归来构建预测风险模型.
- 进行了门德尔的随机化 (MR) 分析,细胞实验,丰富分析和免疫相关分析.
主要成果:
- 确定了八种预后NRGlncRNA和九种预后NRG与COAD患者的结果有显著的关联.
- 使用独立的GEO和GWAS数据集验证了预后模型,显示一致的结果.
- 证明这些基因调节免疫反应,氧化应激和COAD中的免疫逃生.
- 高风险组表现出免疫细胞透和免疫检查点基因表达的增加.
结论:
- 已识别的NRGlncRNAs和NRGs作为COAD的有价值的预后指标.
- 这些分子为改善COAD的临床诊断和治疗提供了潜在的治疗点.
- 这项研究为进一步研究COAD中亡相关途径提供了基础.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K


